Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma
Gilberto de Lima Lopes, Jennifer S. Dicksey, William P. Peters, Melvin Palalay, Alex Y. ChangVolume:
68
Language:
english
Pages:
7
DOI:
10.1007/s00280-011-1588-x
Date:
October, 2011
File:
PDF, 1.56 MB
english, 2011